Literature DB >> 6162034

gA and gB glycoproteins of herpes simplex virus type 1: two forms of a single polypeptide.

R Eberle, R J Courtney.   

Abstract

Utilizing a combination of preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis and sodium dodecyl sulfate-hydroxylapatite column chromatography, we have separated and purified the gA and gB glycoproteins of the major virus-specific glycoprotein region from herpes simplex virus type 1-infected cells. By using purified antigen preparations, antisera specific to each of these glycoproteins were produced. Immunoprecipitation from detergent extracts of infected cells and radioimmune precipitation of the purified antigens have shown that the anti-gA and anti-gB sera each recognize both the gA and the gB glycoproteins. The anti-gA serum was also shown to neutralize virus despite the presence of only minute quantities of the gA glycoprotein in virions. Pulse-chase studies have indicated that the gA and gB glycoproteins are synthesized from a common precursor polypeptide. Together, these data demonstrate that the gA and gB glycoproteins of herpes simplex virus type 1 are antigenically similar but not identical and probably represent two different forms of the same polypeptide which differ in their degree of glycosylation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6162034      PMCID: PMC353694          DOI: 10.1128/JVI.36.3.665-675.1980

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells.

Authors:  K L Powell; R J Courtney
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

2.  Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells.

Authors:  P G Spear
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

3.  Effects of cytochalasin and alkaloid drugs on the biological expression of herpes simplex virus type 2 DNA.

Authors:  F E Farber; R Eberle
Journal:  Exp Cell Res       Date:  1976-11       Impact factor: 3.905

4.  Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens.

Authors:  J C Glorioso; J W Smith
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

5.  A temperature-sensitive mutant of herpes simplex virus type 1 defective in the synthesis of the major capsid polypeptide.

Authors:  D R Bone; R J Courtney
Journal:  J Gen Virol       Date:  1974-07       Impact factor: 3.891

6.  The role of type specific and cross reacting structural antigens in the neutralization of herpes simplex virus types 1 and 2.

Authors:  C Sim; D H Watson
Journal:  J Gen Virol       Date:  1973-05       Impact factor: 3.891

7.  Surface glycopeptides in the envelope of herpes simplex virions.

Authors:  U Olshevsky; Y Becker
Journal:  Virology       Date:  1972-10       Impact factor: 3.616

8.  Type-specific protein in herpes simplex virus envelope reacts with neutralising antibody.

Authors:  K L Powell; A Buchan; C Sim; D H Watson
Journal:  Nature       Date:  1974-05-24       Impact factor: 49.962

9.  Hydroxylapatite chromatography of protein-sodium dodecyl sulfate complexes. A new method for the separation of polypeptide subunits.

Authors:  B Moss; E N Rosenblum
Journal:  J Biol Chem       Date:  1972-08-25       Impact factor: 5.157

10.  Glycoproteins specified by herpes simplex virus type 1: their synthesis, processing and antigenic relatedness to HSV -2 glycoproteins.

Authors:  P G Spear
Journal:  IARC Sci Publ       Date:  1975
View more
  39 in total

1.  Characterization of herpesvirus sylvilagus glycoproteins released into the culture medium of infected cells: antisera to gp13 and gp32 neutralize viral infectivity in vitro and identify antigens on plasma membranes of infected cells.

Authors:  A K Patick; H C Hinze
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes.

Authors:  V C Carter; S R Jennings; P L Rice; S S Tevethia
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

3.  Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus.

Authors:  R L Ashley; L Corey
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

4.  Processing of N-linked oligosaccharides from precursor- to mature-form herpes simplex virus type 1 glycoprotein gC.

Authors:  F Serafini-Cessi; F Dall'Olio; L Pereira; G Campadelli-Fiume
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

5.  Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.

Authors:  N Balachandran; D Harnish; W E Rawls; S Bacchetti
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

6.  Endo-beta-N-acetylglucosaminidase H sensitivity of precursors to herpes simplex virus type 1 glycoproteins gB and gC.

Authors:  E A Wenske; M W Bratton; R J Courtney
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

7.  Herpes simplex virus glycoprotein gA/B: evidence that the infected Vero cell products comap and arise by proteolysis.

Authors:  L Pereira; D Dondero; B Roizman
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

8.  Infectivity and glycoprotein processing of herpes simplex virus type 1 grown in a ricin-resistant cell line deficient in N-acetylglucosaminyl transferase I.

Authors:  G Campadelli-Fiume; L Poletti; F Dall'Olio; F Serafini-Cessi
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

9.  Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.

Authors:  J T Rector; R N Lausch; J E Oakes
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

10.  Glycosylation of herpes simplex virus type 1 gC in the presence of tunicamycin.

Authors:  E A Wenske; R J Courtney
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.